These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37752440)

  • 1. Hepatic steatosis in women with polycystic ovary syndrome.
    Hong X; Guo Z; Yu Q
    BMC Endocr Disord; 2023 Sep; 23(1):207. PubMed ID: 37752440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome.
    Wang D; Nan N; Bing H; He B
    Front Endocrinol (Lausanne); 2023; 14():1241734. PubMed ID: 37720537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome.
    Hong SH; Sung YA; Hong YS; Song DK; Jung H; Jeong K; Chung H; Lee H
    Sci Rep; 2023 Aug; 13(1):13397. PubMed ID: 37591864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance.
    Cai J; Wu CH; Zhang Y; Wang YY; Xu WD; Lin TC; Li SX; Wang LH; Zheng J; Sun Y; Liu W; Tao T
    Int J Obes (Lond); 2017 Sep; 41(9):1341-1347. PubMed ID: 28487551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
    Harsha Varma S; Tirupati S; Pradeep TVS; Sarathi V; Kumar D
    Diabetes Metab Syndr; 2019; 13(2):1065-1069. PubMed ID: 31336445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease.
    Vassilatou E; Vassiliadi DA; Salambasis K; Lazaridou H; Koutsomitopoulos N; Kelekis N; Kassanos D; Hadjidakis D; Dimitriadis G
    Eur J Endocrinol; 2015 Dec; 173(6):739-47. PubMed ID: 26340970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Burden of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome: A Case-Control Study.
    Giannouli A; Efthymiou V; Konidari M; Mani I; Aravantinos L; Dourakis SP; Antoniou A; Deligeoroglou E; Bacopoulou F
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center.
    Taranto DOL; Guimarães TCM; Couto CA; Cândido AL; Azevedo RCS; Mattos FS; Elias MLC; Reis FM; Rocha ALL; Faria LC
    Arch Endocrinol Metab; 2020; 64(3):235-242. PubMed ID: 32555989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population.
    Salva-Pastor N; López-Sánchez GN; Chávez-Tapia NC; Audifred-Salomón JR; Niebla-Cárdenas D; Topete-Estrada R; Pereznuñez-Zamora H; Vidaltamayo-Ramírez R; Báez-Arellano ME; Uribe M; Nuño-Lámbarri N
    Ann Hepatol; 2020; 19(3):251-257. PubMed ID: 32111488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.
    Bohdanowicz-Pawlak A; Lenarcik-Kabza A; Brona A; Kuliczkowska-Płaksej J; Łaczmański Ł; Zaleska-Dorobisz U; Milewicz A
    Endokrynol Pol; 2014; 65(6):416-21. PubMed ID: 25554608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS.
    Petta S; Ciresi A; Bianco J; Geraci V; Boemi R; Galvano L; Magliozzo F; Merlino G; Craxì A; Giordano C
    PLoS One; 2017; 12(11):e0186136. PubMed ID: 29161258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.
    Polyzos SA; Goulis DG; Kountouras J; Mintziori G; Chatzis P; Papadakis E; Katsikis I; Panidis D
    Hormones (Athens); 2014; 13(4):519-31. PubMed ID: 25402369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary pattern in women with polycystic ovary syndrome with and without associated non-alcoholic fatty liver disease: A cross-sectional study.
    Guimarães TCM; Taranto DOL; Couto CA; Nardelli MJ; Cândido AL; Hott CA; Anastácio LR; Reis FM; Rocha ALL; Faria LC
    Clinics (Sao Paulo); 2023; 78():100288. PubMed ID: 38052105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of nonalcoholic fatty liver disease increased with type 2 diabetes mellitus in overweight/obese youth with polycystic ovary syndrome.
    Patel-Sanchez N; Perito E; Tsai P; Raymond-Flesch M; Lodish M; Sarkar M
    J Pediatr Endocrinol Metab; 2023 May; 36(5):441-446. PubMed ID: 37060356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease and polycystic ovary syndrome.
    Vassilatou E
    World J Gastroenterol; 2014 Jul; 20(26):8351-63. PubMed ID: 25024594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?
    Targher G; Rossini M; Lonardo A
    Endocrine; 2016 Feb; 51(2):211-21. PubMed ID: 26024975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome.
    Vassilatou E; Lafoyianni S; Vryonidou A; Ioannidis D; Kosma L; Katsoulis K; Papavassiliou E; Tzavara I
    Hum Reprod; 2010 Jan; 25(1):212-20. PubMed ID: 19887498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease.
    Kim JJ; Kim D; Yim JY; Kang JH; Han KH; Kim SM; Hwang KR; Ku SY; Suh CS; Kim SH; Choi YM
    Aliment Pharmacol Ther; 2017 Jun; 45(11):1403-1412. PubMed ID: 28370150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease in polycystic ovarian syndrome in Indian women.
    Siwatch S; Singh V; Dhaliwal LK; Kumari S; Singh K
    J Obstet Gynaecol; 2022 Jul; 42(5):957-961. PubMed ID: 34689689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.